[{"id":"1a64252e-0479-4435-89c1-05d1fa239123","acronym":"ProGem2","url":"https://clinicaltrials.gov/study/NCT02303912","created_at":"2021-01-18T10:53:45.912Z","updated_at":"2024-07-02T16:36:30.079Z","phase":"Phase 1b","brief_title":"Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer","source_id_and_acronym":"NCT02303912 - ProGem2","lead_sponsor":"Imperial College Healthcare NHS Trust","biomarkers":" MUC16","pipe":"","alterations":" ","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • Acelarin (fosgemcitabine palabenamide)"],"overall_status":"Completed","enrollment":" Enrollment 25","initiation":"Initiation: 11/01/2014","start_date":" 11/01/2014","primary_txt":" Primary completion: 01/23/2017","primary_completion_date":" 01/23/2017","study_txt":" Completion: 01/23/2017","study_completion_date":" 01/23/2017","last_update_posted":"2021-05-18"}]